Search clinical trials for: LM-305

Total 3050 results

LaNova Medicines Zhejiang Co., Ltd.

Active, not recruiting

Study of LM-302 in Patients With Advance Solid Tumors

Advanced Solid Tumor

China
LaNova Australia Pty Limited

Terminated

Study of LaNova Medicines(LM)-302 in Combination With Toripalimab in Patients With Advanced Solid Tumors

Advanced Solid Tumor

Australia
Turning Point Therapeutics, Inc.

Completed

Study of Turning Point Therapeutics LM-302 in Patients With Advance Solid Tumors

Advanced Solid Tumor

United States
Kangbuk Samsung Hospital

Completed

Temporary Simultaneous Two-arterial Occlusions During Laparoscopic Myomectomy (TESTO)

Myoma

Korea, Republic of
LaNova Medicines Development Co., Ltd.
Shanghai Zhongshan Hospital; First Affiliated Hospital of Zhejiang University; Sir Run Run Shaw Hospital and other collaborators

Terminated

Study of LM-102 in Patients With Advance Solid Tumors

Advanced Solid Tumor

China
LaNova Medicines Limited

Recruiting

A Study of LM-24C5 For Advanced Solid Tumors

Advanced Solid Tumor

United States
Henan Cancer Hospital

Recruiting

A Dose Exploration Study of Almonertinib for EGFRm NSCLC Patients With Brain/Leptomeningeal Metastasis (ARTISTRY)

NSCLC | Brain Metastases | Leptomeningeal Metastasis

China
LaNova Medicines Limited

Terminated

A Clinical Study Preliminary Efficacy of LM-061 Tablet in Subjects With Advanced Tumours

Advanced Tumours

China
LaNova Medicines Limited

Recruiting

Study of LM-108 as a Single Agent or in Combination With Toripalimab in Subjects With Advanced Solid Tumours

Advanced Solid Tumor

China
Ganin Fertility Center

Completed

Culture Media Microdroplet Geometry With Different Oil Overlay and Its Effect on Embryonic Development.

Infertility | Embryonic Development

Egypt
Wageningen University

Completed

Fiber Longer Term Study on Energy Intake (FLiTS)

Healthy

Netherlands
LaNova Medicines Limited

Terminated

Study of LM-061 in Subjects in Advanced Tumors

Advanced Tumours

Australia
Taipei Medical University Shuang Ho Hospital
Taipei Medical University WanFang Hospital; Tri-Service General Hospital; Asian...

Not yet recruiting

Comparison Between Robotic (RM) and Laparoscopic Myomectomy (LM)

Surgical Procedure, Unspecified | Uterine Leiomyoma

Taiwan
Lawson Health Research Institute
University of Western Ontario, Canada

Completed

Added-value of SPECT/CT in Patients Undergoing LM/SL for Gynecological Cancers

Cervical Cancer | Vulvar Cancer

Canada
Shanghai Zhongshan Hospital

Recruiting

Candonilimab in Combination With LM-302 for Claudin 18.2 Positive-advanced Biliary Tract Cancer After Failure of Standard of Chemotherapy and PD1/PD-L1 Antibody

Biliary Tract Cancer | Candonilimab | Claudin 18.2

China
Lawson Health Research Institute
University of Western Ontario, Canada; London Regional Cancer Program, Canada

Terminated

SPECT-CT Guided Lymphatic Mapping and Sentinel Lymphadenectomy (LM/SL) in Prostate Cancer

Prostate Cancer

Canada
LaNova Medicines Zhejiang Co., Ltd.

Not yet recruiting

LM-302 for the Treatment of Subjects With Claudin18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma.

Locally Advanced or Metastatic GC and GCJ Adenocarcinoma
LaNova Medicines Limited

Withdrawn

Study of LM-305 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM) and Other Plasma Cell Diseases

Relapsed or Refractory Multiple Myeloma | Other Plasma Cell Diseases
University Magna Graecia

Unknown

Prophylactic Bilateral Salpingectomy and Laparoscopic Myomectomy

Abnormal Uterine Bleeding, Unspecified

Italy
Novindiet Clinic
Tehran University of Medical Sciences; University of Nottingham

Completed

Effect of High Caloric Intake at Lunch Against Dinner on Weight Loss

Obesity | Overweight

Iran, Islamic Republic of
Taipei Medical University WanFang Hospital

Unknown

Extracorporeal Shock Wave in the Treatment of Trigger Finger

Trigger Finger

Taiwan
Advaxis, Inc.

Terminated

An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+ (ADXS11-001)

Cervical Intraepithelial Neoplasia

United States
Cryonove Pharma
CEISO; Dermatech; LTD HEALTH

Completed

Tolerance and Performance (Mode of Administration) of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots

Lentigo Solar | Senile Lentigo

Georgia
Johannes Gutenberg University Mainz

Completed

Gender Specific Differences in Postoperative Sore Throat for Ambu® AuraGain™ Laryngeal Mask (LadyLAMA)

Postoperative Complications | Postoperative Pain

Germany
Advaxis, Inc.

Recruiting

Study of ADXS-503 With or Without Pembro in Subjects With Metastatic Non-Small Cell Lung Cancer

Lung Cancer, Non-Small Cell | Metastatic Squamous Cell Carcinoma | Metastatic Non-Squamous Cell Carcinoma

United States
Eli Lilly and Company

Completed

A Study for Patients With Diabetes Mellitus (IOPA) (IOPA)

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

China
Enanta Pharmaceuticals, Inc

Terminated

A Randomized, Double-blind Study to Assess the Safety and Efficacy of EDP-305 in Subjects With Liver-biopsy Proven NASH

Non-Alcoholic Steatohepatitis

United States, Canada, Puerto Rico, United Kingdom, Argentina, Germany
Southeast University, China

Recruiting

An Efficacy of Simulator Training for Fiberbronchoscopy in Intensivists

Simulator Training

China
Dokuz Eylul University

Completed

Laryngeal Mask Supreme During Laparoscopic Gynecologic Surgery

Anaesthesia

Turkey
Hookipa Biotech GmbH

Recruiting

HB-302/HB-301 Therapy in Participants With Metastatic Castration-Resistant Prostate Cancer

Prostate Cancer Metastatic

United States
Aarhus University Hospital

Unknown

The Safety and Efficacy of a Novel HSP90 Inhibitor (CUDC-305) in the Treatment of Moderate to Severe Psoriasis.

Psoriasis Vulgaris

Denmark
Opsona Therapeutics Ltd.
M.D. Anderson Cancer Center; Montefiore Medical Center; New York Presbyterian... and other collaborators

Completed

A Phase I/II Study of OPN-305 in Second-line Lower Risk Myelodysplastic Syndrome

Myelodysplastic Syndrome

United States
Opsona Therapeutics Ltd.
M.D. Anderson Cancer Center; Montefiore Medical Center; New York Presbyterian... and other collaborators

Completed

Follow up Protocol to the Phase I/II Study of OPN-305 in Second-line or Third-line Lower Lower Risk Myelodysplastic Syndrome

Myelodysplastic Syndrome

United States
Enanta Pharmaceuticals, Inc

Completed

Absorption, Metabolism and Excretion (AME) Study of [14C]EDP-305 in Healthy Male Subjects

NASH - Nonalcoholic Steatohepatitis

United States
Enanta Pharmaceuticals, Inc

Completed

A Study of EDP-305 in Subjects With Mild and Moderate Hepatic Impairment Compared With Normal Healthy Volunteers

NASH

United States, Czechia, Slovakia
LaNova Australia Pty Limited

Recruiting

Study of LM-108 as a Single Agent or in Combination With Anti-PD-1 Antibody in Subjects With Advanced Solid Tumours

Advanced Solid Tumor

Australia
Swiss Tropical & Public Health Institute
Pevion Biotech Ltd; Mymetics Corporation

Completed

Phase Ib Trial of Two Virosome Formulated Malaria Vaccine Components (PEV 301, PEV 302) in Tanzania (PMAL03)

Falciparum Malaria

Tanzania
Enanta Pharmaceuticals, Inc
ICON Clinical Research; Triangle Biostatistics

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis

Non-Alcoholic Steatohepatitis

United States, United Kingdom, New Zealand, Canada, France, Puerto Rico
National Institute of Diabetes and Digestive and...

Not yet recruiting

Pilot Study of Isocaloric Time Restricted Eating on Ketone Metabolism and Immunoregulation

Obesity | Body Weight

United States
Eli Lilly and Company

Completed

Lispro Mid Mixture (MM) Intensive Mixture Therapy With Progressive Dose-Titration of Lispro Low Mixture (LM) or Biphasic Insulin Aspart 30/70 (S019) (S019)

Diabetes Mellitus, Type 2

Croatia, Poland, Romania, South Africa, Turkey
Ligue Pulmonaire Neuchâteloise

Not yet recruiting

A Microphone for Monitoring Coughs (CoughMonit)

Chronic Obstructive Pulmonary Disease | Respiratory Disease

Switzerland
Calcilytix Therapeutics, Inc., a BridgeBio company

Completed

Safety, Tolerability, and Efficacy of Encaleret in Participants With Autosomal Dominant Hypocalcemia (ADH) Type 1

Autosomal Dominant Hypocalcemia (ADH)

United States
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

A Study of EDP 305 in Healthy Subjects and Subjects With Presumptive NAFLD

Presumptive NAFLD

United States
GlucoVista

Unknown

Measuring and Monitoring Blood Glucose Levels Utilizing Non-invasive Blood Glucose Monitoring Device

Diabetes Mellitus Type 1

Israel
LaNova Medicines Limited

Terminated

Study of LM-108 as a Single Agent or in Combination With Pembrolizumab in Subjects With Advanced Solid Tumours

Advanced Solid Tumor

United States
Amgen

Recruiting

Study to Explore the Safety, Tolerability, and Pharmacokinetics of AMG 305 in Subjects With Advanced Solid Tumors

Advanced Solid Tumors

United States, Korea, Republic of, Spain, Australia, Germany, France, Japan, Canada
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates; Triangle Biostatistics

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis

Primary Biliary Cholangitis

United States, Spain, Canada, Australia, United Kingdom, Germany, Netherlands, Belgium, Austria, France
Flame Biosciences

Withdrawn

Phase 1/2a Study to Evaluate FL-301 in Patients With Advanced Solid Tumors

Gastric Cancer | Solid Tumor | Pancreas Cancer
Aarhus University Hospital

Completed

A Double-blind Placebo-controlled Randomized Trial Evaluating the Efficacy and Safety of a Novel HSP90 Inhibitor (RGRN-305) in the Treatment of Moderate to Severe Hidradenitis Supppurativa.

Hidradenitis Suppurativa

Denmark
Dokuz Eylul University

Completed

Comparison of Laryngeal Mask Airway Supreme and Endotracheal Tube In Patients Undergoing Gynecological Laparoscopy Surgery

Anaesthesia

Turkey

Search clinical trials for: LM-305

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations